Results 281 to 290 of about 99,821 (371)

Combined MEK and JAK inhibition reduces osteopontin plasma level and bone marrow fibrosis in a myelofibrosis mouse model. [PDF]

open access: yesBlood Cancer J
Tavernari L   +18 more
europepmc   +1 more source

Serum anti-osteopontin autoantibody as a novel diagnostic and prognostic biomarker in patients with hepatocellular carcinoma

open access: bronze, 2014
Xia Ying   +10 more
openalex   +2 more sources

Early Microbiological and Immunological Parameters in Sandblasted, Large‐Grit Acid‐Etched Implant Surfaces: A Split Mouth Randomized Clinical Trial

open access: yesClinical Oral Implants Research, Volume 37, Issue 2, Page 126-140, February 2026.
ABSTRACT Aim To compare microbiological and immunological parameters of two sandblasted, large‐grit, acid‐etched implant surfaces during the first 8 weeks of healing following implant placement. Materials and Methods A dual‐center, split‐mouth, randomized controlled clinical trial was conducted on patients receiving one test (modified hydrophilic ...
Blanca Vílchez   +11 more
wiley   +1 more source

Non‐Coding RNAs in Breast Cancer Radioresistance: Mechanisms, Functional Roles and Translational Potentials

open access: yesCell Proliferation, Volume 59, Issue 2, February 2026.
Non‐coding RNAs (ncRNAs) regulate breast cancer radioresistance via cell cycle, DNA repair and tumour microenvironment pathways. Targeting ncRNAs (e.g., HOTAIR and miR‐155) with RNA‐based therapies (ASOs and CRISPR) shows promise but faces delivery challenges.
Xiaohui Zhao   +8 more
wiley   +1 more source

Development of an SPRi Immune Method for the Quantitative Detection of Osteopontin. [PDF]

open access: yesSensors (Basel)
Sankiewicz A   +3 more
europepmc   +1 more source

Prediction of transcription factor bindings sites affected by SNPs located at the osteopontin promoter

open access: gold, 2017
Marco A. Briones‐Orta   +5 more
openalex   +1 more source

Effects of Periodontal‐Specific Exosomes and rhBMP2 on Osteogenic Behaviour and Differentiation of BMSCs

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 3, February 2026.
ABSTRACT Growth factors, including recombinant human bone morphogenetic protein‐2 (rhBMP2), have been clinically utilised for large bone augmentation with good outcomes. Nevertheless, long‐term healing, swelling, safety concerns, and high cost limit their use.
Paras Ahmad   +6 more
wiley   +1 more source

Osteopontin regulates dentin and alveolar bone development and mineralization.

open access: yesBone, 2018
B. Foster   +12 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy